back to cluster viewer
cluster path 010111111100
120 words, 13,967 tokens
freq alpha suffix
Words in frequency order
1 | weekly | 7,371
|
2 | monthly | 3,251
|
3 | yearly | 690
|
4 | hourly | 518
|
5 | biweekly | 408
|
6 | quarterly | 376
|
7 | twice-weekly | 225
|
8 | 3-weekly | 119
|
9 | bimonthly | 96
|
10 | thrice-weekly | 89
|
11 | fortnightly | 87
|
12 | bi-weekly | 83
|
13 | 3-monthly | 82
|
14 | 6-monthly | 70
|
15 | unannounced | 52
|
16 | three-monthly | 32
|
17 | bi-monthly | 27
|
18 | every-other-day | 27
|
19 | 2-weekly | 25
|
20 | 4-weekly | 23
|
21 | once-a-week | 23
|
22 | three-weekly | 19
|
23 | half-hourly | 10
|
24 | 15-ml | 9
|
25 | 2x/day | 8
|
26 | 3-hourly | 8
|
27 | enactment-based | 8
|
28 | mid-week | 8
|
29 | midweek | 8
|
30 | minute-by-minute | 8
|
31 | post-colposcopy | 7
|
32 | trimonthly | 7
|
33 | ev-077 | 6
|
34 | therapist-centered | 6
|
35 | 8-weekly | 5
|
36 | black-and-white | 5
|
37 | concentration-based | 5
|
38 | folfox7 | 5
|
39 | half-yearly | 5
|
40 | sce-b | 5
|
41 | semiweekly | 5
|
42 | six-weekly | 5
|
43 | tri-weekly | 5
|
44 | 1540nm | 4
|
45 | 2×/wk | 4
|
46 | 5-weekly | 4
|
47 | honoraria | 4
|
48 | nonpurposeful | 4
|
49 | oxybutinine | 4
|
50 | pollinex-r | 4
|
51 | preembolization | 4
|
52 | 'attempted | 3
|
53 | 1992-1999 | 3
|
54 | 2-monthly | 3
|
55 | 3-hours | 3
|
56 | 35-m | 3
|
57 | 510-mg | 3
|
58 | intra-seasonal | 3
|
59 | two-hourly | 3
|
60 | week-on/week-off | 3
|
61 | weeks.different | 3
|
62 | 18m | 2
|
63 | 3.5-hour | 2
|
64 | 8,533 | 2
|
65 | additonal | 2
|
66 | ax+ | 2
|
67 | counsellor-initiated | 2
|
68 | diary-assisted | 2
|
69 | five-daily | 2
|
70 | front+ | 2
|
71 | gal/pla | 2
|
72 | guttae | 2
|
73 | hysterical | 2
|
74 | oral-lyn | 2
|
75 | post-administrative | 2
|
76 | x/day | 2
|
77 | .75mcg/kg/min | 1
|
78 | 26g | 1
|
79 | 4iu | 1
|
80 | 50,000/mm3 | 1
|
81 | 8h/day | 1
|
82 | 9.3±0.8 | 1
|
83 | 9.6+/-0.8 | 1
|
84 | anti-histaminic | 1
|
85 | asa.ors | 1
|
86 | ayushman-15a | 1
|
87 | ayushman-15b | 1
|
88 | bi-layers | 1
|
89 | cherry-flavored | 1
|
90 | daily/three | 1
|
91 | doxazosin-averaged | 1
|
92 | extracurriculum | 1
|
93 | facility-guided | 1
|
94 | fda-approval | 1
|
95 | fiveacupressure | 1
|
96 | guaiac-impregnated | 1
|
97 | h-atg/csa | 1
|
98 | hbot/placebo | 1
|
99 | hr=training | 1
|
100 | individually-applied | 1
|
101 | interfeeding | 1
|
102 | laboratory-quality | 1
|
103 | montelukast/placebo | 1
|
104 | monthl | 1
|
105 | months.an | 1
|
106 | non-attended | 1
|
107 | pedometer-defined | 1
|
108 | pre-closure | 1
|
109 | quasi-simultaneously | 1
|
110 | repeately | 1
|
111 | sham-magnetotherapy | 1
|
112 | simple-touch | 1
|
113 | suppressive-facilitatory | 1
|
114 | systane® | 1
|
115 | trip-related | 1
|
116 | two-timed | 1
|
117 | vulvoplasty | 1
|
118 | weeks.individualized | 1
|
119 | ×/weekly | 1
|
120 | →classical | 1
|
Words in alphabetical order
1 | 'attempted | 3
|
2 | .75mcg/kg/min | 1
|
3 | 15-ml | 9
|
4 | 1540nm | 4
|
5 | 18m | 2
|
6 | 1992-1999 | 3
|
7 | 2-monthly | 3
|
8 | 2-weekly | 25
|
9 | 26g | 1
|
10 | 2x/day | 8
|
11 | 2×/wk | 4
|
12 | 3-hourly | 8
|
13 | 3-hours | 3
|
14 | 3-monthly | 82
|
15 | 3-weekly | 119
|
16 | 3.5-hour | 2
|
17 | 35-m | 3
|
18 | 4-weekly | 23
|
19 | 4iu | 1
|
20 | 5-weekly | 4
|
21 | 50,000/mm3 | 1
|
22 | 510-mg | 3
|
23 | 6-monthly | 70
|
24 | 8,533 | 2
|
25 | 8-weekly | 5
|
26 | 8h/day | 1
|
27 | 9.3±0.8 | 1
|
28 | 9.6+/-0.8 | 1
|
29 | additonal | 2
|
30 | anti-histaminic | 1
|
31 | asa.ors | 1
|
32 | ax+ | 2
|
33 | ayushman-15a | 1
|
34 | ayushman-15b | 1
|
35 | bi-layers | 1
|
36 | bi-monthly | 27
|
37 | bi-weekly | 83
|
38 | bimonthly | 96
|
39 | biweekly | 408
|
40 | black-and-white | 5
|
41 | cherry-flavored | 1
|
42 | concentration-based | 5
|
43 | counsellor-initiated | 2
|
44 | daily/three | 1
|
45 | diary-assisted | 2
|
46 | doxazosin-averaged | 1
|
47 | enactment-based | 8
|
48 | ev-077 | 6
|
49 | every-other-day | 27
|
50 | extracurriculum | 1
|
51 | facility-guided | 1
|
52 | fda-approval | 1
|
53 | five-daily | 2
|
54 | fiveacupressure | 1
|
55 | folfox7 | 5
|
56 | fortnightly | 87
|
57 | front+ | 2
|
58 | gal/pla | 2
|
59 | guaiac-impregnated | 1
|
60 | guttae | 2
|
61 | h-atg/csa | 1
|
62 | half-hourly | 10
|
63 | half-yearly | 5
|
64 | hbot/placebo | 1
|
65 | honoraria | 4
|
66 | hourly | 518
|
67 | hr=training | 1
|
68 | hysterical | 2
|
69 | individually-applied | 1
|
70 | interfeeding | 1
|
71 | intra-seasonal | 3
|
72 | laboratory-quality | 1
|
73 | mid-week | 8
|
74 | midweek | 8
|
75 | minute-by-minute | 8
|
76 | montelukast/placebo | 1
|
77 | monthl | 1
|
78 | monthly | 3,251
|
79 | months.an | 1
|
80 | non-attended | 1
|
81 | nonpurposeful | 4
|
82 | once-a-week | 23
|
83 | oral-lyn | 2
|
84 | oxybutinine | 4
|
85 | pedometer-defined | 1
|
86 | pollinex-r | 4
|
87 | post-administrative | 2
|
88 | post-colposcopy | 7
|
89 | pre-closure | 1
|
90 | preembolization | 4
|
91 | quarterly | 376
|
92 | quasi-simultaneously | 1
|
93 | repeately | 1
|
94 | sce-b | 5
|
95 | semiweekly | 5
|
96 | sham-magnetotherapy | 1
|
97 | simple-touch | 1
|
98 | six-weekly | 5
|
99 | suppressive-facilitatory | 1
|
100 | systane® | 1
|
101 | therapist-centered | 6
|
102 | three-monthly | 32
|
103 | three-weekly | 19
|
104 | thrice-weekly | 89
|
105 | tri-weekly | 5
|
106 | trimonthly | 7
|
107 | trip-related | 1
|
108 | twice-weekly | 225
|
109 | two-hourly | 3
|
110 | two-timed | 1
|
111 | unannounced | 52
|
112 | vulvoplasty | 1
|
113 | week-on/week-off | 3
|
114 | weekly | 7,371
|
115 | weeks.different | 3
|
116 | weeks.individualized | 1
|
117 | x/day | 2
|
118 | yearly | 690
|
119 | ×/weekly | 1
|
120 | →classical | 1
|
Words in suffix order
1 | front+ | 2
|
2 | ax+ | 2
|
3 | 8,533 | 2
|
4 | 50,000/mm3 | 1
|
5 | ev-077 | 6
|
6 | folfox7 | 5
|
7 | 9.6+/-0.8 | 1
|
8 | 9.3±0.8 | 1
|
9 | 1992-1999 | 3
|
10 | ayushman-15a | 1
|
11 | honoraria | 4
|
12 | gal/pla | 2
|
13 | h-atg/csa | 1
|
14 | sce-b | 5
|
15 | ayushman-15b | 1
|
16 | anti-histaminic | 1
|
17 | unannounced | 52
|
18 | facility-guided | 1
|
19 | non-attended | 1
|
20 | doxazosin-averaged | 1
|
21 | individually-applied | 1
|
22 | two-timed | 1
|
23 | pedometer-defined | 1
|
24 | therapist-centered | 6
|
25 | cherry-flavored | 1
|
26 | concentration-based | 5
|
27 | enactment-based | 8
|
28 | counsellor-initiated | 2
|
29 | trip-related | 1
|
30 | guaiac-impregnated | 1
|
31 | 'attempted | 3
|
32 | diary-assisted | 2
|
33 | weeks.individualized | 1
|
34 | guttae | 2
|
35 | daily/three | 1
|
36 | oxybutinine | 4
|
37 | pre-closure | 1
|
38 | fiveacupressure | 1
|
39 | black-and-white | 5
|
40 | minute-by-minute | 8
|
41 | post-administrative | 2
|
42 | week-on/week-off | 3
|
43 | 26g | 1
|
44 | 510-mg | 3
|
45 | interfeeding | 1
|
46 | hr=training | 1
|
47 | simple-touch | 1
|
48 | once-a-week | 23
|
49 | mid-week | 8
|
50 | midweek | 8
|
51 | 2×/wk | 4
|
52 | hysterical | 2
|
53 | →classical | 1
|
54 | intra-seasonal | 3
|
55 | additonal | 2
|
56 | fda-approval | 1
|
57 | monthl | 1
|
58 | 15-ml | 9
|
59 | nonpurposeful | 4
|
60 | 35-m | 3
|
61 | 18m | 2
|
62 | 1540nm | 4
|
63 | extracurriculum | 1
|
64 | months.an | 1
|
65 | .75mcg/kg/min | 1
|
66 | preembolization | 4
|
67 | oral-lyn | 2
|
68 | hbot/placebo | 1
|
69 | montelukast/placebo | 1
|
70 | pollinex-r | 4
|
71 | 3.5-hour | 2
|
72 | bi-layers | 1
|
73 | asa.ors | 1
|
74 | 3-hours | 3
|
75 | weeks.different | 3
|
76 | 4iu | 1
|
77 | every-other-day | 27
|
78 | 8h/day | 1
|
79 | x/day | 2
|
80 | 2x/day | 8
|
81 | repeately | 1
|
82 | monthly | 3,251
|
83 | 2-monthly | 3
|
84 | 3-monthly | 82
|
85 | 6-monthly | 70
|
86 | three-monthly | 32
|
87 | bi-monthly | 27
|
88 | bimonthly | 96
|
89 | trimonthly | 7
|
90 | five-daily | 2
|
91 | weekly | 7,371
|
92 | 2-weekly | 25
|
93 | 3-weekly | 119
|
94 | 4-weekly | 23
|
95 | 5-weekly | 4
|
96 | 8-weekly | 5
|
97 | thrice-weekly | 89
|
98 | twice-weekly | 225
|
99 | three-weekly | 19
|
100 | bi-weekly | 83
|
101 | tri-weekly | 5
|
102 | six-weekly | 5
|
103 | ×/weekly | 1
|
104 | biweekly | 408
|
105 | semiweekly | 5
|
106 | yearly | 690
|
107 | half-yearly | 5
|
108 | quarterly | 376
|
109 | hourly | 518
|
110 | 3-hourly | 8
|
111 | half-hourly | 10
|
112 | two-hourly | 3
|
113 | quasi-simultaneously | 1
|
114 | fortnightly | 87
|
115 | sham-magnetotherapy | 1
|
116 | post-colposcopy | 7
|
117 | suppressive-facilitatory | 1
|
118 | laboratory-quality | 1
|
119 | vulvoplasty | 1
|
120 | systane® | 1
|